ELECTRA Study: Design

Opinion
Video

A panelist discusses how the phase 2 ELECTRA trial studies elacestrant in combination with ribociclib as first-line therapy for ER+/HER2– advanced breast cancer in postmenopausal women.

Recent Videos
1 KOL is featured in this series.
1 expert in this video
1 expert in this video